CClinicalTrials.gg
CompletedNCT05251623COPDUpdated Feb 23, 2022

Walking Program With Pedometer on Quality of Life in COPD

An interventional study of walking program in Chronic Obstructive Pulmonary Disease, sponsored by Chang Gung University. Completed at 1 site in Taiwan. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2022-02-23.

Sponsored by Chang Gung University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 years 9 months after the study started (first participant enrolled Mar 2018, registered Dec 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the following measurements were performed: pulmonary function test (PFT), daily steps, Six-Minute Walk Test (6MWT), COPD Assessment Test (CAT), and quality of life questionnaire (SF-12).

Read the detailed description

Patients with chronic obstructive pulmonary disease (COPD) are suffered from impaired pulmonary function and dyspnea which result to limited level of physical activity, and impaired quality of life. Exercise and regular physical activity have been proven to break the vicious circle. The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the pulmonary function was assessed by spiromtery test. The exercise capacity were assessed by six-minute walking test, the physical activity level was assessed by daily steps, The quality of life was assessed by COPD Assessment Test (CAT), and quality of life questionnaire (SF-12).

.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • COPD
  • pedometer
  • physical activity
  • quality of life
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 45 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Chang Gung University is the lead sponsor of 63 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. diagnosed with COPD
  2. in a medically stable condition
  3. able to walk unassisted
  4. ≥ 40 years of age

Exclusion criteria

Exclusion Criteria:

  1. oxygen therapy,
  2. hemodynamic instability,
  3. signs/symptoms of acute infection
  4. severe neurological, musculoskeletal, or cardiovascular conditions that affect walking
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    pedometer

    walking with pedometer

    Other: walking program

  • No intervention
    control

    no intervention

Interventions

  • Otherwalking program

    Subjects in PG walked to target steps daily with pedometer for 6 weeks

06

What researchers measure

Primary outcomes

  1. tidal volume

    the amount of air that moves in or out of the lungs with each respiratory cycle. It is measured by spirometers.

    Time frame: week 0

  2. tidal volume

    the amount of air that moves in or out of the lungs with each respiratory cycle. It is measured by spirometers.

    Time frame: week 7

  3. Short-form 12 questionnaire (SF-12)

    The SF-12 is a quality of life questionnaire. The scores range from 0 (worst conceivable QOL) to 100 (best conceivable QOL)

    Time frame: week 0

  4. Short-form 12 questionnaire (SF-12)

    The SF-12 is a quality of life questionnaire. The scores range from 0 (worst conceivable QOL) to 100 (best conceivable QOL)

    Time frame: week 7

  5. 6 minute walking test

    walking distance

    Time frame: week 0

  6. 6 minute walking test

    walking distance

    Time frame: week 7

  7. daily steps

    the number of total walking steps per day which is measured by pedometer.

    Time frame: week0

  8. daily steps

    the number of total walking steps per day which is measured by pedometer.

    Time frame: week 7

07

Study locations

1 site
  • Taoyuan General Hospital
    Taoyuan, 333, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 23, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05251623
Lead sponsor
Chang Gung University
Responsible party
Chen Yen-Huey (assist professor, Chang Gung University) — Principal investigator
First posted
Feb 23, 2022
Start date
Mar 1, 2018
Primary completion
Mar 31, 2018
Completion
Mar 31, 2019
Last update
Feb 23, 2022

Study contacts

Yen-Huey Chen, PhD
principal investigator · Chang Gung University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion